News from the STERN BioRegion

Here we inform you about news from companies and research institutes in the STERN BioRegion.

07/10/2024

HepaRegeniX raises €15 million Series C round to advance clinical development of HRX-215 for liver regeneration

Tuebingen (Germany), July 10, 2024 – HepaRegeniX GmbH, a clinical stage company developing a novel regenerative therapy for the treatment of acute and chronic liver disea...
eng A-_KDB9236.jpg

Review of the 2024 summer reception

Last week, our annual summer reception took place at the observatory in Tübingen and was a complete success! The highlight of the evening was the award ceremony for the Science2Start ideas competition, where innovative and forward-looking projec...
07/03/2024 | CureVac AG

GSK and CureVac to Restructure Collaboration into New Licensing Agreement

London UK; TÜBINGEN, Germany/BOSTON, USA – July 3, 2024 GSK plc (LSE/NYSE: GSK) and CureVac N.V. (Nasdaq: CVAC) today announced they have restructured their existing coll...
Ensinger_Bjoern-Schneekloth_MD_9099.jpg
07/02/2024 | Ensinger GmbH

Björn Schneekloth joins plastics processor Ensinger as Managing Director

Plastics processor Ensinger is expanding its top management. On 1 July, Björn Schneekloth joined the family-owned company as a Managing Director. Together with the two lo...
07/02/2024 | KyooBe Tech GmbH

KyooBe Tech unveils eFIT: a new era in safe and efficient Vaccine Manufacturing

Innovative solutions for pathogen inactivation in research and small-scale manufacturing Leinfelden, Germany – June 28: KyooBe Tech, a pioneer in innovative pharmaceutica...
eng BioFibreLoop_DITF.JPG

Towards a circular and sustainable textile industry in Europe: BioFibreLoop has been started

he German Institutes of Textile and Fiber Research Denkendorf (DITF) are coordinating the research project, which is funded as part of the European Union's Horizon Europe...
eng KE VG Stand biohymed ZIM.jpg

BioRegio STERN at the BMWK 2024 Innovation Day for SMEs

BioRegio STERN was present at this year's Innovation Day for SMEs organised by the Federal Ministry of Economics and Climate Protection. Project manager Dr. Verena Grimm and managing director Dr. Klau...
eng Forschungspreise-Portraits-quer-8650x6000.jpg

Pathogen identification – next-generation sequencing optimizes diagnostics

Invasive infections such as sepsis require immediate and targeted treatment. Experts from the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB and g...
06/11/2024 | TETEC AG

Octane Medical acquires B. Braun’s global orthobiologics business

Kingston, Ontario, Canada / Melsungen, Germany, June 5th, 2024 – Octane Medical Group, through its new venture Octane Biotherapeutics (BioTx), has acquired 100% shares of the global orthobiologics bus...
engl 06-06-2024_Peter Loskill Silke Riegger 3R-Center Ursula Händel Preis 2024_Foto 3R-Center.jpeg

German Research Foundation honors researchers for animal testing alternatives

Prof. Dr. Peter Loskill and Dr. Silke Riegger from the 3R Center Tübingen for in-vitro models and animal testing alternatives have been awarded the Ursula M. Händel Anima...
PBS_synthetic-leather_DITF.jpg

Synthetic leather made from recyclable and bio-based PBS

A new type of pure synthetic leather meets the high requirements of the European Ecodesign Regulation. Made from a bio-based plastic, it is biodegradable and meets the requirements for a closed recycl...
eng  06_06_2024BioRStern19.jpg

Standpoint • Biotech 2024

BioRegio STERN Management GmbH hosted this year's Standpunkt • Biotech in Tübingen. Here are the pictures of the event in a relaxed atmosphere....
NMI_Cleanbench_06 Foto BioRegio STERN_Andreas Körner.jpg

Laboratory and office space management in the STERN BioRegion

BioRegio STERN Management GmbH is now offering a free service for laboratory and office space within the STERN BioRegion. We will be happy to put you in touch.

[DE Copy] Three men stand next to each other. The man in the middle ceremoniously receives a bouquet of flowers.

The University of Stuttgart elects a new Rector

The Senate and University Council of the University of Stuttgart have elected Professor Peter Middendorf, previously the Vice Rector for Knowledge and Technology Transfer, as the new Rector. On October 1, he will succeed Professor Wolfram Ressel...
Schematic representation of an endoscopic camera, a sensor system and a surgical instrument, which together determine the incision margin of a tumor and remove the tumor region.

Research Training Group on Cancer Surgery: German Research Foundation approves second funding period

Since 2019, the Research Training Group (RTG) "Intraoperative Multisensoric Tissue Differentiation in Oncology," a collaboration between the University of Stuttgart and t...
05/23/2024 | CureVac AG

CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update

Organizational redesign on track, trimming residual pandemic infrastructure and reducing 150 positions by year end U.S. FDA Fast Track designation granted for pre-pandem...
image5.jpeg

Immatics Announces First Quarter 2024 Financial Results and Business Update

Updated clinical data on ACTengine® IMA203 targeting PRAME in 30 heavily pre-treated metastatic melanoma patients at RP2D: 55% confirmed objective response rate, includin...
csm_MIK_Nadel_0006321_039aaedb63.jpg

BioCompFinder: New NMI service for manufacturers of innovative medical devices

My medical device is highly innovative. But is it also biocompatible? Medical devices with direct or indirect patient contact are subject to strict rules for approval - f...
04/24/2024 | CureVac AG

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update

TÜBINGEN, Germany/BOSTON, USA – April 24, 2024 CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medici...
04/24/2024 | CureVac AG

CureVac Appoints Thaminda Ramanayake as New Chief Business Officer

TÜBINGEN, Germany/BOSTON, USA – April 24, 2024 CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonuc...